CGH
TECH icon

Crossmark Global Holdings’s Bio-Techne TECH Stock Holding History

Crossmark Global Holdings’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Hold
5,992
– – 0.01% 929
2026
Q1 		$313K Sell
5,992
-4,537
-43% -$272K ﹤0.01% 1001
2025
Q4 		$619K Sell
10,529
-35
-0.3% -$2.13K 0.01% 760
2025
Q3 		$588K Buy
10,564
+13
+0.1% +$696 0.01% 832
2025
Q2 		$543K Sell
10,551
-623
-6% -$31.3K 0.01% 852
2025
Q1 		$655K Buy
11,174
+9
+0.1% +$610 0.01% 755
2024
Q4 		$804K Hold
11,165
– – 0.01% 647
2024
Q3 		$893K Sell
11,165
-90
-0.8% -$6.76K 0.02% 649
2024
Q2 		$807K Sell
11,255
-666
-6% -$49K 0.02% 655
2024
Q1 		$839K Buy
11,921
+107
+0.9% +$7.66K 0.02% 672
2023
Q4 		$911K Sell
11,814
-833
-7% -$54.9K 0.02% 625
2023
Q3 		$878K Sell
12,647
-489
-4% -$38.6K 0.02% 606
2023
Q2 		$1.1M Sell
13,136
-1,508
-10% -$121K 0.02% 565
2023
Q1 		$1.09M Buy
14,644
+3,428
+31% +$264K 0.03% 557
2022
Q4 		$930K Buy
11,216
+2,876
+34% +$228K 0.02% 594
2022
Q3 		$592K Buy
8,340
+108
+1% +$9.33K 0.02% 704
2022
Q2 		$714K Buy
8,232
+800
+11% +$75K 0.02% 673
2022
Q1 		$804K Sell
7,432
-240
-3% -$24.8K 0.02% 706
2021
Q4 		$992K Sell
7,672
-10,920
-59% -$1.34M 0.02% 629
2021
Q3 		$2.25M Buy
18,592
+2,820
+18% +$343K 0.05% 355
2021
Q2 		$1.77M Sell
15,772
-1,320
-8% -$139K 0.04% 425
2021
Q1 		$1.63M Sell
17,092
-280
-2% -$25.5K 0.04% 439
2020
Q4 		$1.38M Buy
17,372
+280
+2% +$20.3K 0.03% 475
2020
Q3 		$1.06M Buy
17,092
+560
+3% +$36.4K 0.03% 518
2020
Q2 		$1.09M Buy
16,532
+960
+6% +$57.5K 0.03% 508
2020
Q1 		$738K Buy
15,572
+320
+2% +$16K 0.03% 549
2019
Q4 		$837K Buy
15,252
+1,732
+13% +$90.9K 0.02% 610
2019
Q3 		$661K Sell
13,520
-644
-5% -$32.3K 0.02% 675
2019
Q2 		$738K Sell
14,164
-376
-3% -$18.9K 0.02% 644
2019
Q1 		$722K Buy
14,540
+848
+6% +$38.2K 0.02% 648
2018
Q4 		$495K Sell
13,692
-9,200
-40% -$384K 0.02% 773
2018
Q3 		$1.17M Sell
22,892
-5,388
-19% -$239K 0.03% 547
2018
Q2 		$1.05M Buy
28,280
+560
+2% +$21.4K 0.03% 583
2018
Q1 		$1.05M Sell
27,720
-6,000
-18% -$212K 0.03% 596
2017
Q4 		$1.09M Buy
33,720
+40
+0.1% +$1.27K 0.03% 614
2017
Q3 		$1.02M Buy
+33,680
New +$999K 0.03% 604
2016
Q3 		$1.02M Buy
+33,680
New +$925K 0.03% 604

Other funds holding TECH

FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Crossmark Global Holdings's TECH Position: Q2 2026 in Review

Crossmark Global Holdings held its Bio-Techne (TECH) position steady in Q2 2026 at 5,992 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #929.

Crossmark Global Holdings first reported a position in TECH in Q3 2016 and has held it in 37 quarters since. The position peaked at $2.25M in Q3 2021. 61 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Crossmark Global Holdings held 5,992 shares of Bio-Techne worth $423K as of Q2 2026.
  • Crossmark Global Holdings left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #929 holding.
  • Crossmark Global Holdings first reported a position in Bio-Techne in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Bio-Techne position peaked at $2.25M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.